Hyperaldosteronism: Difference between revisions
| Line 9: | Line 9: | ||
==Clinical Features== | ==Clinical Features== | ||
* Hypertension (often severe or resistant) | |||
* | |||
* Hypokalemia, which may manifest as: | |||
** | |||
** Weakness | |||
** | |||
** Fatigue | |||
** | |||
** Muscle cramps | |||
** | |||
** Constipation | |||
** | |||
** Paresthesia | |||
* | |||
* Polyuria and polydipsia | |||
* | |||
* Metabolic alkalosis (less commonly symptomatic) | |||
* | |||
* Headache or nonspecific complaints | |||
* | |||
* Asymptomatic in some patients | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Revision as of 23:42, 5 May 2025
Background
Hyperaldosteronism refers to a condition of excess aldosterone secretion, typically leading to sodium retention, potassium excretion, and metabolic alkalosis. It is categorized into:
- Primary hyperaldosteronism (Conn syndrome) – autonomous overproduction of aldosterone, most commonly from an adrenal adenoma or bilateral adrenal hyperplasia.
- Secondary hyperaldosteronism – due to increased renin from conditions like renal artery stenosis, heart failure, or cirrhosis.
Primary hyperaldosteronism is an important and potentially reversible cause of secondary hypertension, accounting for 5–10% of hypertensive cases and up to 20% of treatment-resistant hypertension. It is often underdiagnosed in emergency settings.
Clinical Features
- Hypertension (often severe or resistant)
- Hypokalemia, which may manifest as:
- Weakness
- Fatigue
- Muscle cramps
- Constipation
- Paresthesia
- Polyuria and polydipsia
- Metabolic alkalosis (less commonly symptomatic)
- Headache or nonspecific complaints
- Asymptomatic in some patients
